Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Immunology Letters
|
January 30, 2026
Fc receptor-like proteins and their role in B-cell responses and autoimmune diseases
Christina Haroun, Frans G M Kroese, Gwenny M Verstappen
Rheumatology (Oxford, England)
|
February 17, 2019
T cells in primary Sjögren's syndrome: targets for early intervention
Gwenny M Verstappen, Frans G M Kroese, Hendrika Bootsma
Nature Reviews. Rheumatology
|
April 29, 2021
Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis
Gwenny M Verstappen, Sarah Pringle, Hendrika Bootsma, et al.
Immunology Letters
|
June 14, 2023
Targeting plasma cells in systemic autoimmune rheumatic diseases - Promises and pitfalls
Tobit D Steinmetz, Gwenny M Verstappen, Jolien Suurmond, et al.
Journal of Autoimmunity
|
December 2, 2017
Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity
Gwenny M Verstappen, Odilia B J Corneth, Hendrika Bootsma, et al.
Current Opinion in Immunology
|
February 17, 2026
T cells in Sjögren's disease: update on their role in salivary gland pathogenesis and treatment
Gwenny M Verstappen, Sarah Pringle, Kornelis Sm van der Geest, et al.
Clinical and Experimental Rheumatology
|
October 23, 2020
Blocking T cell co-stimulation in primary Sjögren's syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers
Elena Pontarini, Gwenny M Verstappen, Sofia Grigoriadou, et al.
RMD Open
|
August 31, 2023
Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sjögren's syndrome: a retrospective cohort study
Juan J Fierro, Jelmer R Prins, Gwenny M Verstappen, et al.
Expert Review of Clinical Immunology
|
August 8, 2023
Why do drug treatments fail in Sjögren's disease? Considerations for treatment, trial design and interpretation of clinical efficacy
Suzanne Arends, Gwenny M Verstappen, Liseth de Wolff, et al.
Clinical and Experimental Rheumatology
|
October 13, 2022
Fatigue in primary Sjögren's syndrome is associated with an objective decline in physical performance, pain and depression
Roeland F Prak, Suzanne Arends, Gwenny M Verstappen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Immunology Letters
|
January 30, 2026
Fc receptor-like proteins and their role in B-cell responses and autoimmune diseases
Christina Haroun, Frans G M Kroese, Gwenny M Verstappen
Rheumatology (Oxford, England)
|
February 17, 2019
T cells in primary Sjögren's syndrome: targets for early intervention
Gwenny M Verstappen, Frans G M Kroese, Hendrika Bootsma
Nature Reviews. Rheumatology
|
April 29, 2021
Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis
Gwenny M Verstappen, Sarah Pringle, Hendrika Bootsma, et al.
Immunology Letters
|
June 14, 2023
Targeting plasma cells in systemic autoimmune rheumatic diseases - Promises and pitfalls
Tobit D Steinmetz, Gwenny M Verstappen, Jolien Suurmond, et al.
Journal of Autoimmunity
|
December 2, 2017
Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity
Gwenny M Verstappen, Odilia B J Corneth, Hendrika Bootsma, et al.
Current Opinion in Immunology
|
February 17, 2026
T cells in Sjögren's disease: update on their role in salivary gland pathogenesis and treatment
Gwenny M Verstappen, Sarah Pringle, Kornelis Sm van der Geest, et al.
Clinical and Experimental Rheumatology
|
October 23, 2020
Blocking T cell co-stimulation in primary Sjögren's syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers
Elena Pontarini, Gwenny M Verstappen, Sofia Grigoriadou, et al.
RMD Open
|
August 31, 2023
Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sjögren's syndrome: a retrospective cohort study
Juan J Fierro, Jelmer R Prins, Gwenny M Verstappen, et al.
Expert Review of Clinical Immunology
|
August 8, 2023
Why do drug treatments fail in Sjögren's disease? Considerations for treatment, trial design and interpretation of clinical efficacy
Suzanne Arends, Gwenny M Verstappen, Liseth de Wolff, et al.
Clinical and Experimental Rheumatology
|
October 13, 2022
Fatigue in primary Sjögren's syndrome is associated with an objective decline in physical performance, pain and depression
Roeland F Prak, Suzanne Arends, Gwenny M Verstappen, et al.
Page
of 5